58
Views
42
CrossRef citations to date
0
Altmetric
Original Article

The effect of a modified β-cyclodextrin, SBE4-β-CD, on the aqueous stability and ocular absorption of pilocarpine

, , &
Pages 897-905 | Published online: 02 Jul 2009
 

Abstract

In the present study, the effects of a novel, modified β-cyclodextrin derivative (SBE4-β-CD; a variably substituted sulfobutyl ether of β-cyclodextrin with an average degree of substitution of four) on the aqueous stability of pilocarpine and on its ocular absorption in albino rabbits were studied. For stability reasons, commercial pilocarpine eyedrops are formulated at pH 4–5, a pH range where pilocarpine (pKa ⌣ 7) is almost completely ionized. As shown in the present and past studies, increasing the pH of the pilocarpine solution from 4.5 to 7.0 increases the ocular absorption of pilocarpine. SBE4-β-CD increased the aqueous stability of pilocarpine (0.36 mM) at pH 7.0 (4°C, projected values from Arrhenius data at 25°C, 37°C and 50°C); in the absence of SBE4-β-CD, t90% was 236 days. In the presence of 1 mM and 25 mM of SBE4-β-CD, t90% was 382 days and 2054 days, respectively, suggesting that indeed, pilocarpine does interact with SBE4-β-CD.

SBE4-β-CD did not damage the corneal epithelium in vitro and was well-tolerated by the rabbit eye in vivo Coadministered SBE4-β-CD did not significantly affect the miotic response of pilocarpine solutions at pH values of 4.5 or 7.0 when the molar ratio of SBE4-β-CD to pilocarpine was between 0.2:1–7:1. The effect of the Coadministered SBE4-β-CD on the miotic response of pilocarpine solutions was also compared to that of 2-hydroxy-propyl-β-cyclodextrin (HP-β-CD) which has recently been suggested to increase ocular bioavailability of pilocarpine in rabbits. Our studies could not confirm the earlier observations. Curr. Eye Res. 13: 897–905, 1994.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.